determination and the implementation of preventive, diagnostic or therapeutic medical
strategies. However, the ESC Guidelines do not override in any way whatsoever the …

Aims To systematically assess late outcomes of acute pulmonary embolism (PE) and to
investigate the clinical implications of post-PE impairment (PPEI) fulfilling prospectively …

Pulmonary embolism (PE) represents the third leading cause of cardiovascular mortality.
The technological landscape for management of acute intermediate-and high-risk PE is …

Pulmonary embolism is a common and potentially fatal cardiovascular disorder that must be
promptly diagnosed and treated. The diagnosis, risk assessment, and management of …

Intermediate-risk (submassive) pulmonary embolism (PE) describes normotensive patients
with evidence of right ventricular compromise, whereas high-risk (massive) PE comprises …

Abstract The post-Pulmonary Embolism (post-PE) syndrome is being increasingly
recognized as a long-term consequence of PE. Its most severe manifestation, chronic …

Background The current diagnostic delay of chronic thromboembolic pulmonary
hypertension (CTEPH) after pulmonary embolism (PE) is unacceptably long, causing loss of …

The complete picture of the outcomes of venous thromboembolism (VTE) care consists of
conventional binary clinical outcomes (death, recurrent VTE, and bleeding), patient-centered …

The most important decision in the long-term treatment of venous thromboembolism (VTE) is
how long to anticoagulate. VTE provoked by a reversible risk factor, or a first unprovoked …

ISHLT members have recognized the importance of a consensus statement on the
evaluation and management of patients with chronic thromboembolic pulmonary …